Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy
J Yang, Z Liu - Frontiers in endocrinology, 2022 - frontiersin.org
Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of
diabetes. Microvascular endothelial cells are thought to be the major targets of …
diabetes. Microvascular endothelial cells are thought to be the major targets of …
[HTML][HTML] Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Diabetic retinopathy (DR) causes significant visual loss on a global scale. Treatments for the
vision-threatening complications of diabetic macular edema (DME) and proliferative diabetic …
vision-threatening complications of diabetic macular edema (DME) and proliferative diabetic …
The progress in understanding and treatment of diabetic retinopathy
Diabetic retinopathy is the most frequently occurring complication of diabetes mellitus and
remains a leading cause of vision loss globally. Its aetiology and pathology have been …
remains a leading cause of vision loss globally. Its aetiology and pathology have been …
[HTML][HTML] The pathology associated with diabetic retinopathy
J Lechner, OE O'Leary, AW Stitt - Vision research, 2017 - Elsevier
This review summarizes the pathological features of diabetic retinopathy. The lesions
occurring in the diabetic retina have been described over many decades using descriptive …
occurring in the diabetic retina have been described over many decades using descriptive …
Diabetic microvascular disease: an endocrine society scientific statement
EJ Barrett, Z Liu, M Khamaisi, GL King… - The Journal of …, 2017 - academic.oup.com
Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs.
Our understanding of the genesis of this injury and of potential interventions to prevent, limit …
Our understanding of the genesis of this injury and of potential interventions to prevent, limit …
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data
AM Joussen, F Ricci, LP Paris, C Korn… - Eye, 2021 - nature.com
The ang opoietin/t yrosine kinase with i mmunoglobulin and e pidermal growth factor
homology domains (Ang/Tie) pathway is an emerging key regulator in vascular development …
homology domains (Ang/Tie) pathway is an emerging key regulator in vascular development …
[HTML][HTML] Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography
PL Nesper, PK Roberts, AC Onishi… - … & visual science, 2017 - jov.arvojournals.org
Purpose: We quantified retinal and choriocapillaris microvascular changes in healthy control
eyes and different stages of diabetic retinopathy (DR) using optical coherence tomography …
eyes and different stages of diabetic retinopathy (DR) using optical coherence tomography …
[HTML][HTML] Retinal vessel diameters and function in cardiovascular risk and disease
H Hanssen, L Streese, W Vilser - Progress in retinal and eye research, 2022 - Elsevier
In the last two decades evidence has gradually accumulated suggesting that the eye may be
a unique window for cardiovascular risk stratification based on the assessment of subclinical …
a unique window for cardiovascular risk stratification based on the assessment of subclinical …
Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond
HP Hammes - Diabetologia, 2018 - Springer
Diabetic retinopathy remains a relevant clinical problem. In parallel with diagnostic and
therapeutic improvements, the role of glycaemia and reactive metabolites causing cell stress …
therapeutic improvements, the role of glycaemia and reactive metabolites causing cell stress …
Retinal microglia: just bystander or target for therapy?
Resident microglial cells can be regarded as the immunological watchdogs of the brain and
the retina. They are active sensors of their neuronal microenvironment and rapidly respond …
the retina. They are active sensors of their neuronal microenvironment and rapidly respond …